Nonreactive (negative). This means you're not currently infected with hep C. If you think you've been exposed within the last 6 months, you will need to be tested again to make sure because it can take a while
MichaelSchmidt, MarijkeWeber, Michael P.Busch, Leslie H.Tobler, Bruce H.Phelps, ErhardSeifried, W. KurtRoth. (2005) Yield of hepatitis C virus nucleic acid testing among antibody-reactive or confirmed-positive samples. Transfusion 45 :10.1111/trf.2005.45.issue-6, 1040-1042 /...
A Self-Adjuvanting Multiepitope Immunogen That Induces a Broadly Cross-Reactive Antibody to Hepatitis C Virus[J]. Hepatology, 2007,45:911-920.Torresi J,Stock OM,Fischer AE,et al.A self-adjuvanting multiepitope immunogen that induces a broadly cross-reactive antibody to hepatitis C virus[J]....
Fixed cells were labeled with primary antibodies overnight in antibody-binding buffer (PBS with 0.2% saponin, 0.2% nonfat dry milk, and 1% bovine serum albumin). After washing cells 4 times in PBS, cells were further incubated with fluorescent secondary antibodies for 4 h, rinsed, and mounted...
history of liver disease and non-A, non-B hepatitis (NANBH), number of blood transfusions, number of previous transplants, blood group, panel reactive antibody (PRA) assay, hepatitis B surface antigen (HBsAg), antibody to hepatitis B surface antigen (anti-HBs), antibody to hepatitis B core...
Buffington J, Murray PJ, Schlanger K, et al. Low prevalence of hepatitis C virus antibody in men who have sex with men who do not inject drugs. Public Health Rep 2007; 122 Suppl. 2: 63–7 Google Scholar Cohen DE, Russell CJ, Golub SA, et al. Prevalence of hepatitis C virus infec...
Robert C. A decade of immune-checkpoint inhibitors in cancer therapy. Nat Commun. 2020 ;11(1): 3801. [3] Felip E, Altorki N, Zhou C, et al. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomise...
A vaccine against Hepatitis C virus (HCV) is urgently needed to limit the spread of HCV. The large antigenic diversity of the HCV glycoprotein E1E2 makes it difficult to design a vaccine but also to fully understand the antibody response after infection or vaccination. Here we designed a panel...
5350671HCV immunoassays employing C domain antigens1994-09-27Houghton et al. 5229491Peptides immunochemically reactive with antibodies directed against hepatitis Non-A, Non-B virus1993-07-20Habets et al. 5223400Immunoassay method for determining the specificity of binding of a monoclonal antibody to ...
(Promega). Sections for iNOS immunocytochemistry were blocked with 5% goat serum containing 0.2% bovine serum albumin. Thereafter, sections were incubated for 1 hour at room temperature with anti-iNOS antibody (Transduction Laboratories; 1:300), then washed and probed with a secondary antibody ...